Brain Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Brain Cancer stocks.

Brain Cancer Stocks Recent News

Date Stock Title
Nov 1 UTHR United Therapeutics Q3 Earnings & Sales Beat Estimates
Oct 31 NVCR NovoCure’s Strong Q3 and Leadership Changes in 2024
Oct 31 UTHR United Therapeutics Corp (UTHR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
Oct 31 NVCR NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
Oct 31 UTHR Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
Oct 31 UTHR Q3 2024 United Therapeutics Corp Earnings Call
Oct 31 NVCR NovoCure (NVCR) Q3 2024 Earnings Call Transcript
Oct 30 UTHR United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript
Oct 30 NVCR NovoCure Limited (NVCR) Q3 2024 Earnings Conference Call Transcript
Oct 30 UTHR Here's What Key Metrics Tell Us About United Therapeutics (UTHR) Q3 Earnings
Oct 30 NVCR NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Oct 30 UTHR United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
Oct 30 NVCR Novocure appoints Moderna's exec Christoph Brackmann as CFO
Oct 30 NVCR NovoCure: Q3 Earnings Snapshot
Oct 30 NVCR Novocure Appoints Christoph Brackmann as Chief Financial Officer
Oct 30 NVCR NovoCure GAAP EPS of -$0.28 beats by $0.05, revenue of $155.09M beats by $11.14M
Oct 30 NVCR Novocure Reports Third Quarter 2024 Financial Results
Oct 30 UTHR United Therapeutics: Q3 Earnings Snapshot
Oct 30 UTHR United Therapeutics GAAP EPS of $6.39 misses by $0.03, revenue of $748.9M beats by $26.09M
Oct 30 UTHR United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
Brain Cancer

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors, which start within the brain, and secondary tumors, which have spread from elsewhere, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, problems with vision, vomiting and mental changes. The headache is classically worse in the morning and goes away with vomiting. Other symptoms may include difficulty walking, speaking or with sensations. As the disease progresses, unconsciousness may occur.The cause of most brain tumors is unknown. Uncommon risk factors include inherited neurofibromatosis, exposure to vinyl chloride, Epstein–Barr virus and ionizing radiation. The evidence for mobile phone exposure is not clear. The most common types of primary tumors in adults are meningiomas (usually benign) and astrocytomas such as glioblastomas. In children, the most common type is a malignant medulloblastoma. Diagnosis is usually by medical examination along with computed tomography or magnetic resonance imaging. The result is then often confirmed by a biopsy. Based on the findings, the tumors are divided into different grades of severity.Treatment may include some combination of surgery, radiation therapy and chemotherapy. Anticonvulsant medication may be needed if seizures occur. Dexamethasone and furosemide may be used to decrease swelling around the tumor. Some tumors grow gradually, requiring only monitoring and possibly needing no further intervention. Treatments that use a person's immune system are being studied. Outcome varies considerably depending on the type of tumor and how far it has spread at diagnosis. Glioblastomas usually have poor outcomes, while meningiomas usually have good outcomes. The average five-year survival rate for all brain cancers in the United States is 33%.Secondary, or metastatic, brain tumors are more common than primary brain tumors, with about half of metastases coming from lung cancer. Primary brain tumors occur in around 250,000 people a year globally, making up less than 2% of cancers. In children younger than 15, brain tumors are second only to acute lymphoblastic leukemia as the most common form of cancer. In Australia, the average lifetime economic cost of a case of brain cancer is $1.9 million, the greatest of any type of cancer.

Browse All Tags